Sulfonamide hypersensitivity

Christopher G. Slatore, Stephen A. Tilles

Research output: Contribution to journalArticle

97 Citations (Scopus)

Abstract

Sulfonamides have the potential to elicit many types of adverse drug reactions. Fortunately, severe reactions are uncommon. Significant progress has been made toward understanding the mechanism of hypersensitivity reactions to sulfonamide antibiotics, including the role of metabolic intermediates, the nature of carrier protein substrates, and the possible role of infection and toxic intermediates. There has also been significant progress in addressing the challenge posed by HIV-infected patients who have experienced adverse reactions to sulfonamide antibiotics. Most of these patients can now safely take the drug with the help of a desensitization protocol. Because there are no reliable diagnostic tests to augment the clinical history reported by the patient, for most nonHIV-infected patients presenting with sulfonamide allergy, it is appropriate to counsel indefinite avoidance of the drug. These patients do not necessarily need to avoid all sulfonamide-containing medications, because cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics seems to be uncommon.

Original languageEnglish (US)
Pages (from-to)477-490
Number of pages14
JournalImmunology and Allergy Clinics of North America
Volume24
Issue number3
DOIs
StatePublished - Aug 2004
Externally publishedYes

Fingerprint

Sulfonamides
Hypersensitivity
Anti-Bacterial Agents
Poisons
Drug-Related Side Effects and Adverse Reactions
Routine Diagnostic Tests
Pharmaceutical Preparations
Carrier Proteins
HIV
Infection

ASJC Scopus subject areas

  • Immunology and Allergy

Cite this

Sulfonamide hypersensitivity. / Slatore, Christopher G.; Tilles, Stephen A.

In: Immunology and Allergy Clinics of North America, Vol. 24, No. 3, 08.2004, p. 477-490.

Research output: Contribution to journalArticle

Slatore, Christopher G. ; Tilles, Stephen A. / Sulfonamide hypersensitivity. In: Immunology and Allergy Clinics of North America. 2004 ; Vol. 24, No. 3. pp. 477-490.
@article{02a9fbfbf8224e03b784663528c0eb2f,
title = "Sulfonamide hypersensitivity",
abstract = "Sulfonamides have the potential to elicit many types of adverse drug reactions. Fortunately, severe reactions are uncommon. Significant progress has been made toward understanding the mechanism of hypersensitivity reactions to sulfonamide antibiotics, including the role of metabolic intermediates, the nature of carrier protein substrates, and the possible role of infection and toxic intermediates. There has also been significant progress in addressing the challenge posed by HIV-infected patients who have experienced adverse reactions to sulfonamide antibiotics. Most of these patients can now safely take the drug with the help of a desensitization protocol. Because there are no reliable diagnostic tests to augment the clinical history reported by the patient, for most nonHIV-infected patients presenting with sulfonamide allergy, it is appropriate to counsel indefinite avoidance of the drug. These patients do not necessarily need to avoid all sulfonamide-containing medications, because cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics seems to be uncommon.",
author = "Slatore, {Christopher G.} and Tilles, {Stephen A.}",
year = "2004",
month = "8",
doi = "10.1016/j.iac.2004.03.011",
language = "English (US)",
volume = "24",
pages = "477--490",
journal = "Immunology and Allergy Clinics of North America",
issn = "0889-8561",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Sulfonamide hypersensitivity

AU - Slatore, Christopher G.

AU - Tilles, Stephen A.

PY - 2004/8

Y1 - 2004/8

N2 - Sulfonamides have the potential to elicit many types of adverse drug reactions. Fortunately, severe reactions are uncommon. Significant progress has been made toward understanding the mechanism of hypersensitivity reactions to sulfonamide antibiotics, including the role of metabolic intermediates, the nature of carrier protein substrates, and the possible role of infection and toxic intermediates. There has also been significant progress in addressing the challenge posed by HIV-infected patients who have experienced adverse reactions to sulfonamide antibiotics. Most of these patients can now safely take the drug with the help of a desensitization protocol. Because there are no reliable diagnostic tests to augment the clinical history reported by the patient, for most nonHIV-infected patients presenting with sulfonamide allergy, it is appropriate to counsel indefinite avoidance of the drug. These patients do not necessarily need to avoid all sulfonamide-containing medications, because cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics seems to be uncommon.

AB - Sulfonamides have the potential to elicit many types of adverse drug reactions. Fortunately, severe reactions are uncommon. Significant progress has been made toward understanding the mechanism of hypersensitivity reactions to sulfonamide antibiotics, including the role of metabolic intermediates, the nature of carrier protein substrates, and the possible role of infection and toxic intermediates. There has also been significant progress in addressing the challenge posed by HIV-infected patients who have experienced adverse reactions to sulfonamide antibiotics. Most of these patients can now safely take the drug with the help of a desensitization protocol. Because there are no reliable diagnostic tests to augment the clinical history reported by the patient, for most nonHIV-infected patients presenting with sulfonamide allergy, it is appropriate to counsel indefinite avoidance of the drug. These patients do not necessarily need to avoid all sulfonamide-containing medications, because cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics seems to be uncommon.

UR - http://www.scopus.com/inward/record.url?scp=3042701366&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=3042701366&partnerID=8YFLogxK

U2 - 10.1016/j.iac.2004.03.011

DO - 10.1016/j.iac.2004.03.011

M3 - Article

C2 - 15242722

AN - SCOPUS:3042701366

VL - 24

SP - 477

EP - 490

JO - Immunology and Allergy Clinics of North America

JF - Immunology and Allergy Clinics of North America

SN - 0889-8561

IS - 3

ER -